Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Arch

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Diabetes, Obesity & Metabolism|February 18, 2005
Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazoneE Wargent, C Stocker, P Augstein, et al.
Diabetologia|April 14, 2006
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese miceS J Y Wang, S Birtles, J de Schoolmeester, et al.
International Journal of Obesity (2005)|July 29, 2020
Developmental programming of appetite and growth in male rats increases hypothalamic serotonin (5-HT)5A receptor expression and sensitivityEdward T Wargent, Malgorzata S Martin-Gronert, Roselle L Cripps, et al.
Archives of Biochemistry and Biophysics|February 10, 2015
The effects of sarcolipin over-expression in mouse skeletal muscle on metabolic activityJohn Butler, Neil Smyth, Robert Broadbridge, et al.
Lipids in Health and Disease|January 12, 2005
Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activationEd Wargent, Matthew V Sennitt, Claire Stocker, et al.
The British Journal of Nutrition|November 1, 2012
Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat contentMohamed Bellahcene, Jacqueline F O'Dowd, Ed T Wargent, et al.
The Journal of Nutritional Biochemistry|October 18, 2008
Identification of a novel agonist of peroxisome proliferator-activated receptors alpha and gamma that may contribute to the anti-diabetic activity of guggulipid in Lep(ob)/Lep(ob) miceClaire L Cornick, Barbara H Strongitharm, Gary Sassano, et al.
Diabetes, Obesity & Metabolism|January 29, 2011
A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese miceR A Ngala, C J Stocker, A G Roy, et al.
Disease Models & Mechanisms|January 16, 2016
5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male ratsMalgorzata S Martin-Gronert, Claire J Stocker, Edward T Wargent, et al.
International Journal of Obesity (2005)|November 30, 2011
Leanness in postnatally nutritionally programmed rats is associated with increased sensitivity to leptin and a melanocortin receptor agonist and decreased sensitivity to neuropeptide YC J Stocker, E T Wargent, M S Martin-Gronert, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Diabetes, Obesity & Metabolism|February 18, 2005
Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazoneE Wargent, C Stocker, P Augstein, et al.
Diabetologia|April 14, 2006
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese miceS J Y Wang, S Birtles, J de Schoolmeester, et al.
International Journal of Obesity (2005)|July 29, 2020
Developmental programming of appetite and growth in male rats increases hypothalamic serotonin (5-HT)5A receptor expression and sensitivityEdward T Wargent, Malgorzata S Martin-Gronert, Roselle L Cripps, et al.
Archives of Biochemistry and Biophysics|February 10, 2015
The effects of sarcolipin over-expression in mouse skeletal muscle on metabolic activityJohn Butler, Neil Smyth, Robert Broadbridge, et al.
Lipids in Health and Disease|January 12, 2005
Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activationEd Wargent, Matthew V Sennitt, Claire Stocker, et al.
The British Journal of Nutrition|November 1, 2012
Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat contentMohamed Bellahcene, Jacqueline F O'Dowd, Ed T Wargent, et al.
The Journal of Nutritional Biochemistry|October 18, 2008
Identification of a novel agonist of peroxisome proliferator-activated receptors alpha and gamma that may contribute to the anti-diabetic activity of guggulipid in Lep(ob)/Lep(ob) miceClaire L Cornick, Barbara H Strongitharm, Gary Sassano, et al.
Diabetes, Obesity & Metabolism|January 29, 2011
A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese miceR A Ngala, C J Stocker, A G Roy, et al.
Disease Models & Mechanisms|January 16, 2016
5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male ratsMalgorzata S Martin-Gronert, Claire J Stocker, Edward T Wargent, et al.
International Journal of Obesity (2005)|November 30, 2011
Leanness in postnatally nutritionally programmed rats is associated with increased sensitivity to leptin and a melanocortin receptor agonist and decreased sensitivity to neuropeptide YC J Stocker, E T Wargent, M S Martin-Gronert, et al.
Pageof 10